[ad_1]
SJMC is well positioned to drive the private hospital space into its next growth phase, capturing market share and sustaining its leadership in the coming years.
SAN ANTONIO, July 12, 2022 /PRNewswire/ — Recently, Frost & Sullivan researched the Malaysian hospital industry and, based on its analysis results, recognizes Subang Jaya Medical Centre (SJMC) with the 2022 Company of the Year Award. The company is accredited by Joint Commission International (JCI) and the Malaysian Society for Quality in Health (MSQH), and its medical laboratories are certified by the International Organization for Standardization (ISO) . As part of the Ramsay Sime Darby Health Care Group, SJMC ensures its medical practitioners and administrative staff provide top-notch private healthcare. The multi-disciplinary private healthcare service provider has a capacity of 444 beds, a long history, and remarkable milestones, all contributing to its leadership position in Malaysia’s medical industry. SJMC is the first to conduct the following in Malaysia:
- Stem cell bone marrow transplant (private sector) and live-related pediatric liver transplant
- Open heart surgery (private sector)
- Daycare Total knee replacement surgery
- Brain neurosurgery
- Adult and pediatric bone marrow transplants in the private sector, completing over …
Full story available on Benzinga.com
[ad_2]
Source link
